T-PORT
DEAD

Serial Number

79364693

Owner

Transcutan AB

Attorney

Alexander Lazouski

Filing Date

Nov 24, 2022

Add to watchlist:

No watchlists yet
View on USPTO

T-PORT Trademark

Serial Number: 79364693

T-PORT is a trademark filed by Transcutan AB on November 24, 2022. The trademark is classified under Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Transcutan AB (4 trademarks)

Forskargatan 20J

Entity Type: 16

Trademark Details

Filing Date

November 24, 2022

Registration Date

Not Registered

Goods & Services

Medical and veterinary apparatus and instruments, namely, apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; medical apparatus and instruments, namely, apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; surgical apparatus and instruments; diagnostic, examination, and monitoring equipment, namely, apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; diagnostic apparatus for medical purposes, namely, apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; tools for medical diagnostics, namely, apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; medical apparatus for preparing access to the bloodstream and gastrointestinal tract; medical apparatus for dosing of drugs and nutrients to the bloodstream and gastrointestinal tract; valves for medical apparatus and instruments for providing transcutaneous access to the blood circulation and the gastrointestinal tract and for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; implantable medical apparatus and instruments, namely implantable access device for providing transcutaneous access to the blood circulation and the gastrointestinal tract and for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; catheter skin anchor medical instruments; medical devices for placing and securing catheters

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 29, 2025 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Aug 12, 2025 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 12, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 24, 2024 OPNX
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 12, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 12, 2024 ABN2
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 7, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 7, 2024 OPNR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 29, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2023 TROA
REFUSAL PROCESSED BY IB
May 31, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 8, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 8, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 18, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 17, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 14, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 9, 2023 REPR